Quick Takeaways
- Dellora Investments LP filed SCHEDULE 13G for TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX).
- Disclosed ownership: 6.9%.
- Date of event: 27 Nov 2024.
Dellora Investments LP - 27 Nov 2024 SCHEDULE 13G Report for TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX)
- Filing Manager
- Dellora Investments LP
- Reporting Manager
- Dellora Investments LP
- Symbol
- TENX
- Shares outstanding
- 3,402,797 shares
- Disclosed Ownership
- 234,793 shares
- Ownership
- 6.9%
- Form type
- SCHEDULE 13G
- Filing time
- 05 Dec 2024, 13:47:30 UTC
- Date of event
- 27 Nov 2024
- Next filing
- 15 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Dellora Investments LP disclosed 6.9% ownership in TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX) on 27 Nov 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Dec 2024, 13:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Dellora Investments Master Fund LP | 5.9% | 202,404 | 0 | 202,404 | /s/ Kevin Pyun | Principal, Dellora Investments Fund GP LLC, its General Partner | |
| Dellora Investments LP | 6.9% | 234,793 | 0 | 234,793 | /s/ Kevin Pyun | Principal, Dellora Investments GP LLC, its General Partner | |
| Kevin Pyun | 6.9% | 234,793 | 0 | 234,793 | /s/ Kevin Pyun | Kevin Pyun |